July 2017

For the fourth consecutive year at the Michigan Growth Capital Symposium, technology transfer and commercialization officials from leading research universities and medical centers hosted a fast-paced, hour-long presentation of the research opportunities, spending and sector focus at their respective institutions. They also showcased early stage projects emerging from their medical... Read More

Early stage life science companies face a daunting number of hurdles as they try to build great teams with the right leadership and capabilities to accelerate growth and hit key milestones. It’s not as easy as it sounds, agreed a panel of venture capitalists and entrepreneurs during a discussion on... Read More

Major pharmaceutical and med-tech corporations are ramping up their participation as co-investors, or limited partners, in venture capital funds focused on early stage startups in the life science sector. Many also are establishing their own venture investment arms to compete with traditional VCs for early stakes in the most-promising new... Read More